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LETTERS TO THE EDITOR
Cutaneous Delayed-Type Hypersensitivity Response is
Inhibited in Transgenic Mice with Keratinocyte-Specific CD44
Expression Defect
To the Editor:
CD44 is a polymorphic membrane glycoprotein which has
several isoforms generated by alternative splicing and post-
translational modifications (Stamenkovic et al, 1991; Screaton
et al, 1992). While the CD44H or the standard isoform is
widely expressed on both mesenchymal and epithelial cells,
variant exon-containing CD44 isoforms are found essentially in
cells of epithelial origin (Stamenkovic et al, 1991). CD44
functions as the principal cell-surface receptor for hyaluronate
(HA; Aruffo et al, 1990), and has been implicated in cell–cell
and cell–extracellular matrix adhesion (Lesley et al, 1993), cell
migration (Thomas et al, 1992), lymphocyte recirculation, homing
and activation (Jalkanen et al, 1986; Shimizu et al, 1989),
hematopoiesis (Miyake et al, 1990), and tumor growth and
metastasis (Gunthert et al, 1991; Bartolazzi et al, 1994). CD44–
HA interaction is thought to play a major part in most of these
functions. CD44 is also involved in HA uptake and degradation
(Culty et al, 1992).
In a recent study we have developed transgenic mice that
express an antisense CD44 cDNA driven by the keratin-5
promoter in the basal cell compartment of the stratified squamous
epithelia and the outer root sheath (ORS) of hair follicles (K5-
CD44 anti-sense transgenic mice; Kaya et al, 1997). These mice
lack CD44 expression in the epidermis and ORS of hair follicles,
and display massive HA accumulation in the superficial dermis,
morphologic alterations of basal and follicular keratinocytes, and
defective keratinocyte proliferation, leading to a decrease in skin
elasticity, impaired tissue repair, delayed hair regrowth, and lack
of mitogen- and carcinogen-induced epidermal hyperplasia. These
results suggest that CD44 regulates keratinocyte proliferation in
response to external stimuli and maintains local HA homeostasis
in the skin. In view of these observations, we explored the
effect of CD44 expression loss in keratinocytes on the generation
of local cutaneous inflammation.
We tested the ability of K5-CD44 antisense transgenic mice
with a keratinocyte-specific CD44 expression defect to mount
a delayed-type hypersensitivity (DTH) response to local application
of hapten. For this purpose, 20 µl of 0.5% 2,4-dinitro-1-
fluorobenzene (DNFB) (Sigma, St. Louis, MO) in 4:1 acetone/
olive oil (Sigma) were applied to the rear footpads of mice for
2 successive days. Four days later, mice were challenged by
applying 10 µl of 0.2% DNFB (in the same vehicle) to each
side of the left ear. The right ear of the mice was treated only
with the vehicle. Ear thickness was measured before challenge
and at 24 and 48 h postchallenge, using an engineer’s micrometer
(H. C. Kroeplin GmbH, Schluechtern, Germany). Each ear was
measured twice, for a total of four measurements per animal.
In control mice, a normal inflammatory response beginning
at 24 h postchallenge was observed, characterized by tissue
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edema and leukocyte infiltration. Transgenic mice, however,
showed an inhibited DTH response following hapten stimulation
(Fig 1a). Histologic analysis of the DTH sites after 48 h
demonstrated that in the transgenic mice both the edema and
cellular infiltrate associated with inflammation were reduced
(Fig 1b, c).
The results of our previous study suggested that the
consequences of the CD44 expression loss in the epidermis of
the K5-CD44 antisense transgenic mice might be a result of
the excessive HA accumulation in the dermis, defective
keratinocyte proliferation, or of both. These observations indicate
that the cutaneous DTH response is inhibited in these mice as well.
The observed inhibition of lymphocyte migration to the site
of hapten stimulation in transgenic mice may also be a
consequence of the absence of CD44 on the keratinocytes,
excessive HA accumulation in the dermis or a combination of
both. In a recent study it was shown that injection of anti-
CD44v10 into mice inhibited edema and granuloma formation
in DTH reaction (Rosel et al, 1997). As with other situations
characterized by increased cellular migration, such as the
developing embryonic limb bud, inflammation, and tumor
invasion (Evered and Whelan, 1989), HA synthesis within the
DTH site is enhanced (Campbell et al, 1982). After challenge,
antigen-primed T cells are restimulated and release cytokines
that promote increased vascular permeability and leukocyte
activation, and extravasation in both the DTH site and the
draining lymph nodes (Issekutz et al, 1988). HA-rich edema
precedes the cellular infiltrate, and is maximal by 24 h
postchallenge (Ba¨ck and Groth, 1983). The subsequent migration
of cells into DTH sites in mice is characterized by the early
influx of mononuclear cells (1–12 h postchallenge), followed by
the enhanced extravasation of lymphocytes, neutrophils, and
eosinophils (12–24 h). By 24 h, lymphocytes predominate
(Phanuphak et al, 1974; Ba¨ck and Groth, 1983). Activated
lymphocytes express high levels of CD44, and lymphocyte
migration into the HA-rich DTH site has been shown to be
dependent on CD44–HA interaction in the generation of the
early phase of cutaneous DTH response in mice (Camp et al,
1993). Inhibition of leukocyte migration to the DTH site in
the transgenic mice seems to be surprising as the dermis contains
large amounts of HA. It is well documented that high
concentrations of HA inhibit macrophage migration (Shannon
et al, 1980), raising the possibility that the inability of the
transgenic mice to mount an appropriate DTH response may
be due to excessive HA-mediated inhibition of leukocyte
infiltration, or in other words, of its efferent phase. It cannot
be excluded, however, that the inductive or afferent phase of
contact hypersensitivity, e.g., dendritic cell migration from the
skin to lymph nodes which is a prerequisite for sensitization to
haptens, is also impaired in the transgenic mice, although the
number of dendritic cells in the epidermis of the control and
transgenic mice is not significantly different (data not shown).
These findings are consistent with our previous observations
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Figure 1. Analysis of DTH response. Transgenic mice fail to exhibit a normal DTH response after hapten challenge (a). DNFB-sensitized control and
transgenic mice (five per group) were challenged on the ears with DNFB, and mean ear swelling was determined 24 and 48 h later. Results of the three
different experiments are expressed as the percentage increase in ear thickness (mean value of challenged ears measured at the indicated times postchallenge
minus mean value before challenge) 6 SEM. Transgenic mice showed a reduced ear swelling that was statistically significant at 24 and 48 h (p , 0.005
and p 5 0.01, respectively, Student’s t test). Hematoxylin and eosin-stained sections of ears 48 h after DNFB challenge of control littermates (b) and
transgenic mice (c). Note the decreased edema and cellular infiltrate in transgenic mice. Original magnification, 3 20.
with tetradecanoylphorbolacetate (TPA). Local application of TPA
caused an acute cutaneous inflammatory response characterized by
a marked infiltration of dermis by polymorphonuclear cells in
control mice, which was absent in K5 antisense transgenic mice
(Kaya et al, 1997).
Our results indicate that CD44 plays an important role in the
regulation of cutaneous DTH reaction. Further studies with K5
CD44-antisense transgenic mice will shed light on the molecular
mechanisms of CD44-mediated inflammatory responses in the skin.
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